Article
Today, RxGenomix is pleased to announce that the American Pharmacists Association (APhA) will provide continuing pharmacy education credit for its training program in Pharmacogenomics, offering nearly 300,000 registered pharmacists access to education on the rapidly advancing science of pharmacogenomics.
PRESS RELEASE
Franklin, TN - Today, RxGenomix is pleased to announce that the American Pharmacists Association (APhA) will provide continuing pharmacy education credit for its training program in Pharmacogenomics, offering nearly 300,000 registered pharmacists access to education on the rapidly advancing science of pharmacogenomics.
The 16-hour course was created through a collaboration between RxGenomix and Manchester University to help working pharmacists learn about the science of pharmacogenomics as it relates to their clinical practice. Since launching online in 2015, the course has also been tailored for easy integration into curricula at colleges/schools of pharmacy. The course content was specifically designed to address the ACPE Standards 2016* as well as the pharmacist competencies from the Genetics/Genomics Competency Center, and is available immediately.
“It is becoming clear that integration of pharmacogenomics into pharmacy practice is refining medication therapy and benefitting patients,” says David Kisor, BS, PharmD, RPh, Department of Pharmaceutical Sciences chair and director of the Master of Science in Pharmacogenomics program at Manchester University. “To increase the appropriate use of pharmacogenomics, education must reach a broader population of pharmacists. Bringing this information, in such an accessible format, to APhA membership is going to help the profession add new and significant value to medication therapy management.”
The RxGenomix training program is a collaboration between leaders in professional pharmacy practice and academia. Primary authors of the course include Dr. Kisor and Dr. David Bright, PharmD, BCACP, associate professor of Pharmacy at Ferris State University. The course content thoroughly addresses the genetic basis for individual differences in metabolizing enzymes, transporters, and other biochemicals that have an impact on drug disposition and action that underpin the practice of precision (personalized) medicine.
This activity has been planned and implemented in line with the accreditation requirements and policies of the Accreditation Council for Pharmacy Education (ACPE) by the American Pharmacists Association (APhA) and RxGenomix. APhA is accredited by the ACPE to provide continuing education for pharmacists.
* Accreditation Council for Pharmacy Education (ACPE) Standards and Key Elements for the Professional Program in
Pharmacy Leading to the Doctor of Pharmacy Degree.